Your browser doesn't support javascript.
loading
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial.
Slagter, Astrid E; Vollebergh, Marieke A; Caspers, Irene A; van Sandick, Johanna W; Sikorska, Karolina; Lind, Pehr; Nordsmark, Marianne; Putter, Hein; Braak, Jeffrey P B M; Meershoek-Klein Kranenbarg, Elma; van de Velde, Cornelis J H; Jansen, Edwin P M; Cats, Annemieke; van Laarhoven, Hanneke W M; van Grieken, Nicole C T; Verheij, Marcel.
Afiliación
  • Slagter AE; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vollebergh MA; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Caspers IA; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Sandick JW; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Sikorska K; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lind P; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Nordsmark M; Department of Oncology, Stockholm Söder Hospital, Stockholm, Sweden.
  • Putter H; Karolinska Institutet, Stockholm, Sweden.
  • Braak JPBM; Department of Medical Oncology, Aarhus University, Aarhus, Denmark.
  • Meershoek-Klein Kranenbarg E; Department of Biometrics, Leiden University Medical Center, Leiden, The Netherlands.
  • van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Jansen EPM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Cats A; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • van Laarhoven HWM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van Grieken NCT; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Verheij M; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Gastric Cancer ; 25(2): 401-410, 2022 Mar.
Article en En | MEDLINE | ID: mdl-34714423
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / ADN Tumoral Circulante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / ADN Tumoral Circulante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos